investment

Study underway in Montreal to estimate how many children and teens have been infected with SARS-CoV-2

Today, Canada’s COVID-19 Immunity Task Force (CITF) announces its support for a research project that will estimate how many children and teens in Montreal have been infected with SARS-CoV-2, the virus that causes COVID-19. This $720,000 investment will allow us to better understand how much virus transmission has occurred to children and teens, and [...]

2021-02-26T10:40:25-05:00October 20, 2020|Media Releases|

Investing in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians

Canada's COVID-19 Immunity Task Force (CITF) announces its support for a new SARS-CoV-2 seroprevalence study focused on aging Canadians, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease.  This $4 million investment will be carried out by the Canadian Longitudinal Study on Aging (CLSA), a national platform for research [...]

2021-02-26T10:42:09-05:00October 1, 2020|Media Releases|
Go to Top